Clinical Trials for Cat Scratch Disease

Currently registered clinical trials for Cat Scratch Disease from ClinicalTrials.gov. 0 recruiting, 2 total studies.

This content is for informational purposes only. Always consult a healthcare professional.

Source: ClinicalTrials.gov — U.S. National Library of Medicine — A database of privately and publicly funded clinical studies conducted around the world (U.S. National Library of Medicine, public domain).

This page lists clinical trials related to Cat Scratch Disease from the ClinicalTrials.gov database.

Trial Summary

  • Total studies: 2
  • Recruiting: 0
  • Active, not recruiting: 0
  • Completed: 1
  • Other: 1

Results are refreshed periodically and may not reflect the most current information available from ClinicalTrials.gov.

Completed Trials

NCT03132116 — Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease’s Lymphadenitis

StatusCompleted
PhasePhase 3
SponsorUniversity Hospital, Toulouse
Enrollment75
Study TypeINTERVENTIONAL
ConditionsCat-Scratch Disease
Interventions;

To compare effect of intra-nodal injection of gentamicin versus placebo on the outcome at 28 days of suppurated cat scratch disease’s (CSD) lymphadenitis treated by oral azithromycin.

Other (Unknown)

NCT01469702 — The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease

StatusUnknown
PhasePhase 4
SponsorTel-Aviv Sourasky Medical Center
Enrollment10
Study TypeINTERVENTIONAL
ConditionsCat-scratch Disease; Bartonella Infections
Interventions; ;

Bartonella henselae is the etiologic agent of cat scratch disease (CSD). 90% of patients present with regional lymphadenitis (typical CSD) while 10% will have disease involving other organs, such as neuroretinitis, arthropathy, erythema nodosum, and encephalitis (atypical CSD). In most CSD cases resolution occurs in 2 to 3 months although a prolonged course often occurs. Data on the efficacy of…